Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
40
LABD Quote, Financials, Valuation and Earnings
Last price:
$7.09
Seasonality move
:
6.89%
Day range:
$6.92 - $7.57
52-week range:
$4.78 - $11.41
Dividend yield:
4.2%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
24.1M
Avg. volume:
23.1M
1-year change:
-42.6%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
LABD
Direxion Daily S&P Biotech Bear 3X Shares
|
-- | -- | -- | -- | -- |
|
DRV
Direxion Daily Real Estate Bear 3X Shares
|
-- | -- | -- | -- | -- |
|
DXD
ProShares UltraShort Dow30
|
-- | -- | -- | -- | -- |
|
EDZ
Direxion Daily MSCI Emerging Markets Bear 3x Shs
|
-- | -- | -- | -- | -- |
|
EPV
ProShares UltraShort FTSE Europe
|
-- | -- | -- | -- | -- |
|
SKF
ProShares UltraShort Financials
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
LABD
Direxion Daily S&P Biotech Bear 3X Shares
|
$7.10 | -- | -- | -- | $0.06 | 4.2% | -- |
|
DRV
Direxion Daily Real Estate Bear 3X Shares
|
$30.38 | -- | -- | -- | $0.30 | 4.96% | -- |
|
DXD
ProShares UltraShort Dow30
|
$26.99 | -- | -- | -- | $0.41 | 5.6% | -- |
|
EDZ
Direxion Daily MSCI Emerging Markets Bear 3x Shs
|
$8.92 | -- | -- | -- | $0.11 | 5.43% | -- |
|
EPV
ProShares UltraShort FTSE Europe
|
$42.10 | -- | -- | -- | $0.68 | 4.86% | -- |
|
SKF
ProShares UltraShort Financials
|
$35.68 | -- | -- | -- | $0.59 | 8.2% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
LABD
Direxion Daily S&P Biotech Bear 3X Shares
|
-- | -6.551 | -- | -- |
|
DRV
Direxion Daily Real Estate Bear 3X Shares
|
-- | -5.183 | -- | -- |
|
DXD
ProShares UltraShort Dow30
|
-- | -2.018 | -- | -- |
|
EDZ
Direxion Daily MSCI Emerging Markets Bear 3x Shs
|
-- | -1.911 | -- | -- |
|
EPV
ProShares UltraShort FTSE Europe
|
-- | -2.120 | -- | -- |
|
SKF
ProShares UltraShort Financials
|
-- | -1.672 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
LABD
Direxion Daily S&P Biotech Bear 3X Shares
|
-- | -- | -- | -- | -- | -- |
|
DRV
Direxion Daily Real Estate Bear 3X Shares
|
-- | -- | -- | -- | -- | -- |
|
DXD
ProShares UltraShort Dow30
|
-- | -- | -- | -- | -- | -- |
|
EDZ
Direxion Daily MSCI Emerging Markets Bear 3x Shs
|
-- | -- | -- | -- | -- | -- |
|
EPV
ProShares UltraShort FTSE Europe
|
-- | -- | -- | -- | -- | -- |
|
SKF
ProShares UltraShort Financials
|
-- | -- | -- | -- | -- | -- |
Direxion Daily S&P Biotech Bear 3X Shares vs. Competitors
-
Which has Higher Returns LABD or DRV?
Direxion Daily Real Estate Bear 3X Shares has a net margin of -- compared to Direxion Daily S&P Biotech Bear 3X Shares's net margin of --. Direxion Daily S&P Biotech Bear 3X Shares's return on equity of -- beat Direxion Daily Real Estate Bear 3X Shares's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LABDDirexion Daily S&P Biotech Bear 3X Shares-- -- -- DRVDirexion Daily Real Estate Bear 3X Shares-- -- -- -
What do Analysts Say About LABD or DRV?
Direxion Daily S&P Biotech Bear 3X Shares has a consensus price target of --, signalling downside risk potential of --. On the other hand Direxion Daily Real Estate Bear 3X Shares has an analysts' consensus of -- which suggests that it could fall by --. Given that Direxion Daily S&P Biotech Bear 3X Shares has higher upside potential than Direxion Daily Real Estate Bear 3X Shares, analysts believe Direxion Daily S&P Biotech Bear 3X Shares is more attractive than Direxion Daily Real Estate Bear 3X Shares.
Company Buy Ratings Hold Ratings Sell Ratings LABDDirexion Daily S&P Biotech Bear 3X Shares0 0 0 DRVDirexion Daily Real Estate Bear 3X Shares0 0 0 -
Is LABD or DRV More Risky?
Direxion Daily S&P Biotech Bear 3X Shares has a beta of -2.374, which suggesting that the stock is 337.401% less volatile than S&P 500. In comparison Direxion Daily Real Estate Bear 3X Shares has a beta of -2.816, suggesting its less volatile than the S&P 500 by 381.628%.
-
Which is a Better Dividend Stock LABD or DRV?
Direxion Daily S&P Biotech Bear 3X Shares has a quarterly dividend of $0.06 per share corresponding to a yield of 4.2%. Direxion Daily Real Estate Bear 3X Shares offers a yield of 4.96% to investors and pays a quarterly dividend of $0.30 per share. Direxion Daily S&P Biotech Bear 3X Shares pays -- of its earnings as a dividend. Direxion Daily Real Estate Bear 3X Shares pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LABD or DRV?
Direxion Daily S&P Biotech Bear 3X Shares quarterly revenues are --, which are smaller than Direxion Daily Real Estate Bear 3X Shares quarterly revenues of --. Direxion Daily S&P Biotech Bear 3X Shares's net income of -- is lower than Direxion Daily Real Estate Bear 3X Shares's net income of --. Notably, Direxion Daily S&P Biotech Bear 3X Shares's price-to-earnings ratio is -- while Direxion Daily Real Estate Bear 3X Shares's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Direxion Daily S&P Biotech Bear 3X Shares is -- versus -- for Direxion Daily Real Estate Bear 3X Shares. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LABDDirexion Daily S&P Biotech Bear 3X Shares-- -- -- -- DRVDirexion Daily Real Estate Bear 3X Shares-- -- -- --
-
Which has Higher Returns LABD or DXD?
ProShares UltraShort Dow30 has a net margin of -- compared to Direxion Daily S&P Biotech Bear 3X Shares's net margin of --. Direxion Daily S&P Biotech Bear 3X Shares's return on equity of -- beat ProShares UltraShort Dow30's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LABDDirexion Daily S&P Biotech Bear 3X Shares-- -- -- DXDProShares UltraShort Dow30-- -- -- -
What do Analysts Say About LABD or DXD?
Direxion Daily S&P Biotech Bear 3X Shares has a consensus price target of --, signalling downside risk potential of --. On the other hand ProShares UltraShort Dow30 has an analysts' consensus of -- which suggests that it could fall by --. Given that Direxion Daily S&P Biotech Bear 3X Shares has higher upside potential than ProShares UltraShort Dow30, analysts believe Direxion Daily S&P Biotech Bear 3X Shares is more attractive than ProShares UltraShort Dow30.
Company Buy Ratings Hold Ratings Sell Ratings LABDDirexion Daily S&P Biotech Bear 3X Shares0 0 0 DXDProShares UltraShort Dow300 0 0 -
Is LABD or DXD More Risky?
Direxion Daily S&P Biotech Bear 3X Shares has a beta of -2.374, which suggesting that the stock is 337.401% less volatile than S&P 500. In comparison ProShares UltraShort Dow30 has a beta of -1.669, suggesting its less volatile than the S&P 500 by 266.885%.
-
Which is a Better Dividend Stock LABD or DXD?
Direxion Daily S&P Biotech Bear 3X Shares has a quarterly dividend of $0.06 per share corresponding to a yield of 4.2%. ProShares UltraShort Dow30 offers a yield of 5.6% to investors and pays a quarterly dividend of $0.41 per share. Direxion Daily S&P Biotech Bear 3X Shares pays -- of its earnings as a dividend. ProShares UltraShort Dow30 pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LABD or DXD?
Direxion Daily S&P Biotech Bear 3X Shares quarterly revenues are --, which are smaller than ProShares UltraShort Dow30 quarterly revenues of --. Direxion Daily S&P Biotech Bear 3X Shares's net income of -- is lower than ProShares UltraShort Dow30's net income of --. Notably, Direxion Daily S&P Biotech Bear 3X Shares's price-to-earnings ratio is -- while ProShares UltraShort Dow30's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Direxion Daily S&P Biotech Bear 3X Shares is -- versus -- for ProShares UltraShort Dow30. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LABDDirexion Daily S&P Biotech Bear 3X Shares-- -- -- -- DXDProShares UltraShort Dow30-- -- -- --
-
Which has Higher Returns LABD or EDZ?
Direxion Daily MSCI Emerging Markets Bear 3x Shs has a net margin of -- compared to Direxion Daily S&P Biotech Bear 3X Shares's net margin of --. Direxion Daily S&P Biotech Bear 3X Shares's return on equity of -- beat Direxion Daily MSCI Emerging Markets Bear 3x Shs's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LABDDirexion Daily S&P Biotech Bear 3X Shares-- -- -- EDZDirexion Daily MSCI Emerging Markets Bear 3x Shs-- -- -- -
What do Analysts Say About LABD or EDZ?
Direxion Daily S&P Biotech Bear 3X Shares has a consensus price target of --, signalling downside risk potential of --. On the other hand Direxion Daily MSCI Emerging Markets Bear 3x Shs has an analysts' consensus of -- which suggests that it could fall by --. Given that Direxion Daily S&P Biotech Bear 3X Shares has higher upside potential than Direxion Daily MSCI Emerging Markets Bear 3x Shs, analysts believe Direxion Daily S&P Biotech Bear 3X Shares is more attractive than Direxion Daily MSCI Emerging Markets Bear 3x Shs.
Company Buy Ratings Hold Ratings Sell Ratings LABDDirexion Daily S&P Biotech Bear 3X Shares0 0 0 EDZDirexion Daily MSCI Emerging Markets Bear 3x Shs0 0 0 -
Is LABD or EDZ More Risky?
Direxion Daily S&P Biotech Bear 3X Shares has a beta of -2.374, which suggesting that the stock is 337.401% less volatile than S&P 500. In comparison Direxion Daily MSCI Emerging Markets Bear 3x Shs has a beta of -2.218, suggesting its less volatile than the S&P 500 by 321.84%.
-
Which is a Better Dividend Stock LABD or EDZ?
Direxion Daily S&P Biotech Bear 3X Shares has a quarterly dividend of $0.06 per share corresponding to a yield of 4.2%. Direxion Daily MSCI Emerging Markets Bear 3x Shs offers a yield of 5.43% to investors and pays a quarterly dividend of $0.11 per share. Direxion Daily S&P Biotech Bear 3X Shares pays -- of its earnings as a dividend. Direxion Daily MSCI Emerging Markets Bear 3x Shs pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LABD or EDZ?
Direxion Daily S&P Biotech Bear 3X Shares quarterly revenues are --, which are smaller than Direxion Daily MSCI Emerging Markets Bear 3x Shs quarterly revenues of --. Direxion Daily S&P Biotech Bear 3X Shares's net income of -- is lower than Direxion Daily MSCI Emerging Markets Bear 3x Shs's net income of --. Notably, Direxion Daily S&P Biotech Bear 3X Shares's price-to-earnings ratio is -- while Direxion Daily MSCI Emerging Markets Bear 3x Shs's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Direxion Daily S&P Biotech Bear 3X Shares is -- versus -- for Direxion Daily MSCI Emerging Markets Bear 3x Shs. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LABDDirexion Daily S&P Biotech Bear 3X Shares-- -- -- -- EDZDirexion Daily MSCI Emerging Markets Bear 3x Shs-- -- -- --
-
Which has Higher Returns LABD or EPV?
ProShares UltraShort FTSE Europe has a net margin of -- compared to Direxion Daily S&P Biotech Bear 3X Shares's net margin of --. Direxion Daily S&P Biotech Bear 3X Shares's return on equity of -- beat ProShares UltraShort FTSE Europe's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LABDDirexion Daily S&P Biotech Bear 3X Shares-- -- -- EPVProShares UltraShort FTSE Europe-- -- -- -
What do Analysts Say About LABD or EPV?
Direxion Daily S&P Biotech Bear 3X Shares has a consensus price target of --, signalling downside risk potential of --. On the other hand ProShares UltraShort FTSE Europe has an analysts' consensus of -- which suggests that it could fall by --. Given that Direxion Daily S&P Biotech Bear 3X Shares has higher upside potential than ProShares UltraShort FTSE Europe, analysts believe Direxion Daily S&P Biotech Bear 3X Shares is more attractive than ProShares UltraShort FTSE Europe.
Company Buy Ratings Hold Ratings Sell Ratings LABDDirexion Daily S&P Biotech Bear 3X Shares0 0 0 EPVProShares UltraShort FTSE Europe0 0 0 -
Is LABD or EPV More Risky?
Direxion Daily S&P Biotech Bear 3X Shares has a beta of -2.374, which suggesting that the stock is 337.401% less volatile than S&P 500. In comparison ProShares UltraShort FTSE Europe has a beta of -1.996, suggesting its less volatile than the S&P 500 by 299.646%.
-
Which is a Better Dividend Stock LABD or EPV?
Direxion Daily S&P Biotech Bear 3X Shares has a quarterly dividend of $0.06 per share corresponding to a yield of 4.2%. ProShares UltraShort FTSE Europe offers a yield of 4.86% to investors and pays a quarterly dividend of $0.68 per share. Direxion Daily S&P Biotech Bear 3X Shares pays -- of its earnings as a dividend. ProShares UltraShort FTSE Europe pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LABD or EPV?
Direxion Daily S&P Biotech Bear 3X Shares quarterly revenues are --, which are smaller than ProShares UltraShort FTSE Europe quarterly revenues of --. Direxion Daily S&P Biotech Bear 3X Shares's net income of -- is lower than ProShares UltraShort FTSE Europe's net income of --. Notably, Direxion Daily S&P Biotech Bear 3X Shares's price-to-earnings ratio is -- while ProShares UltraShort FTSE Europe's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Direxion Daily S&P Biotech Bear 3X Shares is -- versus -- for ProShares UltraShort FTSE Europe. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LABDDirexion Daily S&P Biotech Bear 3X Shares-- -- -- -- EPVProShares UltraShort FTSE Europe-- -- -- --
-
Which has Higher Returns LABD or SKF?
ProShares UltraShort Financials has a net margin of -- compared to Direxion Daily S&P Biotech Bear 3X Shares's net margin of --. Direxion Daily S&P Biotech Bear 3X Shares's return on equity of -- beat ProShares UltraShort Financials's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LABDDirexion Daily S&P Biotech Bear 3X Shares-- -- -- SKFProShares UltraShort Financials-- -- -- -
What do Analysts Say About LABD or SKF?
Direxion Daily S&P Biotech Bear 3X Shares has a consensus price target of --, signalling downside risk potential of --. On the other hand ProShares UltraShort Financials has an analysts' consensus of -- which suggests that it could fall by --. Given that Direxion Daily S&P Biotech Bear 3X Shares has higher upside potential than ProShares UltraShort Financials, analysts believe Direxion Daily S&P Biotech Bear 3X Shares is more attractive than ProShares UltraShort Financials.
Company Buy Ratings Hold Ratings Sell Ratings LABDDirexion Daily S&P Biotech Bear 3X Shares0 0 0 SKFProShares UltraShort Financials0 0 0 -
Is LABD or SKF More Risky?
Direxion Daily S&P Biotech Bear 3X Shares has a beta of -2.374, which suggesting that the stock is 337.401% less volatile than S&P 500. In comparison ProShares UltraShort Financials has a beta of -1.921, suggesting its less volatile than the S&P 500 by 292.085%.
-
Which is a Better Dividend Stock LABD or SKF?
Direxion Daily S&P Biotech Bear 3X Shares has a quarterly dividend of $0.06 per share corresponding to a yield of 4.2%. ProShares UltraShort Financials offers a yield of 8.2% to investors and pays a quarterly dividend of $0.59 per share. Direxion Daily S&P Biotech Bear 3X Shares pays -- of its earnings as a dividend. ProShares UltraShort Financials pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LABD or SKF?
Direxion Daily S&P Biotech Bear 3X Shares quarterly revenues are --, which are smaller than ProShares UltraShort Financials quarterly revenues of --. Direxion Daily S&P Biotech Bear 3X Shares's net income of -- is lower than ProShares UltraShort Financials's net income of --. Notably, Direxion Daily S&P Biotech Bear 3X Shares's price-to-earnings ratio is -- while ProShares UltraShort Financials's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Direxion Daily S&P Biotech Bear 3X Shares is -- versus -- for ProShares UltraShort Financials. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LABDDirexion Daily S&P Biotech Bear 3X Shares-- -- -- -- SKFProShares UltraShort Financials-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
